Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study.
暂无分享,去创建一个
D. Clifford | M. Ritchie | G. Robbins | A. Motsinger-Reif | D. Haas | M. Eichelbaum | E. Acosta | M. Schwab | E. Schaeffeler | H. Ribaudo | U. Zanger | R. Gulick | Huan Liu | G. Morse